Tagged: General Medical
Information of general medical nature that relates to fluoroquinolones.
One culprit that is often overlooked in chronic Fluoroquinolone toxicity is small intestinal bacterial overgrowth, or SIBO.
Dr. Miriam J. de Jonge M.D., who herself was floxed has contacted me and asked me to post, what I feel, is a comprehensive and well documented “Dear Colleague” letter, informing other doctors of (FQ) toxicity. It can be used to foster patient/doctor discussions. It is available here to download.
“You can’t do what I do and think the drug companies don’t notice you.” With the media scrutiny and the Citizen Petitions filed over the last year you can bet that Bennett has gotten the attention of some very powerful entities; entities that are going to push back in an effort to silence or undermine our message.
I have found that there is a great misconception by many, including doctors, about the concept of senescence. Most believe it is just simply ‘old age’, but its far more….
Recently an internal memo dated April 17, 2013, issued by the Food and Drug Administration’s Center Drug Evaluation and Research, Office of Surveillance and Epidemiology, was obtained through the freedom of information act shows the FQs in a damning light.
A simple three step action that logically links FQ’s to the ability to initiate delayed adverse “late effect” reactions. There are no grand leaps of faith or conjecture required to link the steps.
Theoretically, the use of pharmaceuticals, even those that are not designated antibiotics, can exert negative influences on your body’s microbiome and contribute to antibiotic resistance.
Since our physiology is not static and things such as enzyme levels and trace mineral are in a constant state of flux, not to mention genetic variances, all which affect metabolization, combined with the fact that the FQ molecule is very complex, there is no way of determining if the same decomposed and identifiable compound will form an adduct in each person.
Have you taken a fluoroquinolone antibiotic such as Cipro (ciprofloxacin), Levaquin (levofloxacin), or Avelox (moxifloxacin)? Would you be willing to help in a survey-based medical research study?
I would have to say that we are one of the most complex subset of patients that can be seen by a physician. More often than not, we often leave the average physician scratching his head as to how to diagnose or treat our condition. Keeping that context in mind, I have determined that I will never see another nurse practitioner again.